Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 903 | 688 | 556 | 387 | 152 |
| Gross Profit | 903 | 688 | 556 | 387 | 152 |
| Operating Expenses | 2,922 | 2,608 | 2,164 | 2,422 | 3,647 |
| Operating Income | -2,018 | -1,919 | -1,607 | -2,035 | -3,495 |
| Interest Expense | 79 | 1,149 | 1,091 | 831 | 279 |
| Other Income | 23 | 32 | 1,038 | 21 | 114 |
| Pre-tax Income | -2,074 | -3,036 | -1,660 | -2,845 | -3,659 |
| Income Tax | N/A | 50 | 83 | N/A | N/A |
| Net Income Continuous | -2,074 | -3,085 | -1,742 | -2,845 | -3,659 |
| Net Income | $-2,074 | $-3,085 | $-1,742 | $-2,845 | $-3,659 |
| EPS Basic Total Ops | -0.12 | -0.18 | -0.12 | -0.22 | -0.30 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.12 | -0.22 | -0.30 |
| EPS Diluted Total Ops | -0.12 | -0.18 | -0.12 | -0.22 | -0.30 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.12 | -0.22 | -0.30 |
| EBITDA(a) | $-2,012 | $-870 | $-797 | $-1,528 | $-3,199 |